PRISCILLA PENNINGS: Open Payments
NPI 1679313738 · BRISTOL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 76 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $420 · 2025 $1,325
Food & beverage: $1,325
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 28 | $440 |
| Madrigal Pharmaceuticals | 10 | $294 |
| Gilead Sciences, Inc. | 13 | $195 |
| Aimmune Therapeutics, Inc. | 11 | $167 |
| Ardelyx, Inc. | 9 | $137 |
| Daiichi Sankyo Inc. | 2 | $41 |
| Novo Nordisk Inc | 2 | $34 |
| Intercept Pharmaceuticals, Inc. | 1 | $17 |
Products named: XIFAXAN, REZDIFFRA, ZENPEP, IBSRELA, INJECTAFER, Wegovy, OCALIVA.
Industry payments across TN — which companies pay providers there.
